Leanabl Logo
udilabelingmfdsfdamdr

UDI Implementation Compared: MFDS, FDA, and EU MDR Timelines

6 min read

Unique Device Identification (UDI) requirements differ across Korea, EU, and US. A unified UDI strategy reduces operational complexity for multinational manufacturers.

Stephen JeongFounder, Leanabl Inc.
UDI Implementation Compared: MFDS, FDA, and EU MDR Timelines

What Is UDI

UDI enables:

  • Adverse event tracking and recalls
  • Counterfeit detection
  • Inventory management in hospitals
  • Real-world evidence collection
  • Supply chain transparency

UDI Comparison Across Jurisdictions

Aspect MFDS (Korea) FDA (USA) EU MDR
Framework UDI System for Medical Devices (2022) FDA UDI Rule (2013) EU MDR Articles 27-29 (2017)
Database KUDI (한국의료기기 UDI 정보시스템) GUDID (Global UDI Database) EUDAMED
Issuing agencies GS1 Korea, HIBCC, ICCBBA GS1, HIBCC, ICCBBA GS1, HIBCC, ICCBBA, IFA
Class I implementation 2027 2022 (final phase) 2025
Class II implementation 2025 2018 2023
Class III/IV implementation 2022 2014 2021
Direct mark on device Required for permanent reusable devices Required for implantables/reusable Required for reusable devices
AIDC format GS1-128, Data Matrix, QR Code GS1, HIBCC formats GS1, HIBCC formats

MFDS UDI System (KUDI)

The Korean UDI system is newest and still in phased rollout.

KUDI Phased Implementation

Phase Effective Date Device Class
Phase 1 2022-07-01 Class IV (highest risk)
Phase 2 2023-07-01 Class III
Phase 3 2025-07-01 Class II
Phase 4 2027-07-01 Class I

KUDI Database Submission

For each Korean-marketed device:

  1. Obtain UDI from MFDS-recognized issuing agency (GS1 Korea, HIBCC, ICCBBA)
  2. Register device data in KUDI database
  3. Apply UDI to labels and packaging
  4. Submit UDI through KLH

KUDI registration includes ~40 data elements about the device.

Unified UDI Strategy

For manufacturers in all 3 jurisdictions:

Step 1: Single Issuing Agency

Use one issuing agency (typically GS1) across all jurisdictions. Single DI per device works for FDA, EU, and MFDS.

Step 2: Unified Database Strategy

Database Submission Approach
GUDID (FDA) Direct submission
EUDAMED (EU MDR) Direct submission via Notified Body relationship
KUDI (MFDS) Submission via KLH

Step 3: Label Implementation

Single UDI label that contains:

  • DI (unique to model)
  • PI (lot/serial/expiration)
  • AIDC barcode (GS1-128 or Data Matrix)
  • Human-readable interpretation

Same UDI satisfies all 3 jurisdictions.

Step 4: Update Management

Changes to device require UDI database updates in all relevant jurisdictions:

  • GUDID update for FDA
  • EUDAMED update for EU MDR
  • KUDI update for MFDS (via KLH)

Common UDI Implementation Mistakes

Mistake 1: Separate UDI Per Jurisdiction

Different issuing agencies, different DIs for same device across jurisdictions.

Fix: Single issuing agency, single DI globally.

Mistake 2: KUDI Registration Delayed

Korean device registered but KUDI database submission missed.

Risk: MFDS audit finding; potential market access issues.

Fix: KUDI submission within 30 days of MFDS approval.

Mistake 3: Direct Mark Requirements Missed

Reusable devices require direct mark UDI on device, not just on packaging.

Risk: Inspection finding; compliance gap.

Fix: Direct marking added at manufacturing for reusable devices.

Mistake 4: PI Format Inconsistency

Different production identifier formats across batches.

Risk: Tracking complexity; recall response slowness.

Fix: Standardized PI format across all manufacturing.

Mistake 5: AIDC Quality Issues

Barcode scans fail; UDI not machine-readable.

Risk: Hospital adoption issues; tracking ineffective.

Fix: Print quality validation; periodic scan testing.

KUDI Specific Requirements

Required Data Elements (KUDI)

Beyond standard UDI elements, KUDI requires:

  • Korean device name
  • Korean classification code
  • KMD number (MFDS license number)
  • KLH information
  • Manufacturer information
  • Korean indications for use

KUDI Submission Workflow

  1. Device approved by MFDS (KMD issued)
  2. KLH coordinates UDI assignment with issuing agency
  3. KLH submits KUDI registration via MFDS portal
  4. KUDI registration confirmed
  5. Device packaging produced with UDI
  6. Korean market launch

KUDI Update Triggers

Database updates required for:

  • Device label changes
  • Manufacturer information changes
  • KLH changes
  • Product discontinuation
  • Significant device changes

Cost of UDI Implementation

Component Initial Cost Annual Cost
Issuing agency fees $3K–$15K $1K–$5K
Label design and validation $5K–$20K Minimal
Database submission setup $5K–$15K per jurisdiction $2K–$5K per jurisdiction
Update management Variable $5K–$20K
Total $20K–$70K $10K–$35K

Frequently Asked Questions

Q: Can we use the same UDI in Korea as we use for FDA?

A: Yes, the Device Identifier (DI) portion can be identical. KUDI accepts UDIs from GS1, HIBCC, and ICCBBA, same as FDA. Korean database registration is the additional step.

Q: What if our device has multiple package configurations?

A: Each unique package configuration requires separate UDI (different DI). Common for kit-based devices.

Q: Do accessories require UDI?

A: Yes if separately distributed. Accessories sold only with the device may share UDI with device.

Q: How does Leanabl help with KUDI?

A: Leanabl's Labeling Services include UDI strategy and KUDI submission coordination through KLH.

Q: What's the penalty for KUDI non-compliance?

A: MFDS may issue compliance notice or restrict market sales. Penalties scale with non-compliance severity.

How Leanabl Helps

Contact Leanabl for UDI strategy.


Last updated: 2026-05-15.

Have a regulatory question?

Talk to a Korea regulatory specialist about your device, your timeline, or your next submission.

Talk to a specialist